{
    "id": 31080,
    "fullName": "MTOR Y1974H",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "MTOR Y1974H lies within TPR repeat 16 of the Mtor protein (UniProt.org). Y1974H results in increased S6K1 phosphorylation and altered cell cycle compared to wild-type Mtor in cell culture, and is associated with increased phospho-ERK and S6 in patient samples (PMID: 29118224).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 12392,
                    "pubMedId": 29118224,
                    "title": "Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel MTOR-Activating Mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29118224"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2475,
        "geneSymbol": "MTOR",
        "terms": [
            "MTOR",
            "FRAP",
            "FRAP1",
            "FRAP2",
            "RAFT1",
            "RAPT1",
            "SKS"
        ]
    },
    "variant": "Y1974H",
    "createDate": "09/25/2019",
    "updateDate": "09/26/2019",
    "referenceTranscriptCoordinates": {
        "id": 183672,
        "transcript": "NM_004958",
        "gDna": "chr1:g.11128117A>G",
        "cDna": "c.5920T>C",
        "protein": "p.Y1974H",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 18507,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a human kidney cancer cell line expressing MTOR Y1974H demonstrated sensitivity to Rapamune (sirolimus) treatment in culture (PMID: 29118224).",
            "molecularProfile": {
                "id": 33382,
                "profileName": "MTOR Y1974H"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 263,
                "name": "kidney cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 12392,
                    "pubMedId": 29118224,
                    "title": "Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel MTOR-Activating Mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29118224"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20714,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, Afinitor (everolimus) treatment resulted in a partial response in 2 patient with renal cell carcinoma harboring MTOR Y1974H, with a progression-free survival of 9 and 89 months, respectively (PMID: 31335987).",
            "molecularProfile": {
                "id": 33382,
                "profileName": "MTOR Y1974H"
            },
            "therapy": {
                "id": 735,
                "therapyName": "Everolimus",
                "synonyms": null
            },
            "indication": {
                "id": 4450,
                "name": "renal cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 18013,
                    "pubMedId": 31335987,
                    "title": "PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31335987"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 18989,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a clear cell renal cell carcinoma patient harboring MTOR Y1974H, who also harbored additional BAP1 E454Rfs*15 and VHL W88L variants, demonstrated a partial response with time to best response of 6 weeks following treatment with Torisel (temsirolimus), and continued on treatment for more than 7 years (PMID: 29118224).",
            "molecularProfile": {
                "id": 33382,
                "profileName": "MTOR Y1974H"
            },
            "therapy": {
                "id": 936,
                "therapyName": "Temsirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 4467,
                "name": "clear cell renal cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 12392,
                    "pubMedId": 29118224,
                    "title": "Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel MTOR-Activating Mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29118224"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 33382,
            "profileName": "MTOR Y1974H",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 33793,
            "profileName": "BAP1 E454Rfs*15 MTOR Y1974H VHL W88L",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 183673,
            "transcript": "XM_005263438",
            "gDna": "chr1:g.11128117A>G",
            "cDna": "c.5920T>C",
            "protein": "p.Y1974H",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 183672,
            "transcript": "NM_004958",
            "gDna": "chr1:g.11128117A>G",
            "cDna": "c.5920T>C",
            "protein": "p.Y1974H",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}